PGY2 Pediatrics

Purpose

Selena Li and Meagan Funasaki - PGY2 Pediatric Pharmacy Residents

The UCSF PGY2 residency program builds upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.

Description

The pediatric residency is a one-year ASHP-accredited specialty residency that allows the opportunity for the pediatric resident to strengthen his/her clinical skills by focusing on providing pharmaceutical care to pediatric patients. UCSF Benioff Children’s Hospital is a 189-bed children’s hospital and is part of UCSF Medical Center. The children’s hospital includes 58 neonatal ICU beds, 37 hematology/oncology/BMT beds, 28 general pediatric and surgical beds, 28 transitional care beds (transplant and cardiac step-down), 38 ICU beds, and 36 obstetrics and labor and delivery beds. The primary emphasis of the program is to provide in-depth clinical experience in a variety of areas within pediatric and neonatal medicine. The pharmacy resident will be a core member of the interdisciplinary medical team during the acute care rotations and will participate in patient care rounds on a daily basis. There is also a significant teaching component associated with this residency program, and the resident will earn a teaching certificate. The UCSF Medical Center is closely affiliated with the UCSF School of Pharmacy, and the resident will have the opportunity to teach Doctor of Pharmacy students in two courses in the School of Pharmacy and precept Doctor of Pharmacy students throughout the year. 

Learning Experiences

Rotation Schedule

At a minimum, each resident will spend two thirds or more of their time involved in direct patient care activities. PGY2 Pediatric residents must complete 5 core rotations which can be customized to accommodate a longer experience and may be repeated as "Part II" to incorporate advanced learning experience elements. Multiple electives may be selected based on the amount of time available after initial customization of core rotations. Repeat rotation electives for additional clinical focus are variable in length with a minimum of 2 - 3 weeks.

Specialty pathway residents (Critical Care or Oncology) will spend at least 50% of their year focused on their specialty field, and projects will be tailored (as possible) to focus on the specialty field.

  • PGY2 Pediatrics with added Critical Care specialty pathway will include a minimum of 26 weeks in critical care areas including PICU, CICU, NICU (ICN) and Emergency Medicine as required rotations.  Additional required rotations include Gen Peds (3 weeks), Heme/Onc (3 weeks), Admin/Med Use Projects (7 weeks) with additional time for electives or rotation extension.
  • PGY2 Pediatrics with added Oncology specialty pathway will include a minimum of 26 weeks in oncology areas including Heme/Onc I/II, BMT I, II, and Oncology Ambulatory Care as required rotations. Additional required rotations include Gen Peds (3 weeks), PICU (4 weeks), Admin/Med Use Projects (7 weeks) with additional time for electives or rotation extension.

Sequencing of Learning Experiences

Initial rotation sequencing is based on resident rotation preferences. Sequencing and scheduled learning experiences are modified and customized during the year based on resident interest and performance. Final elective rotation at the end of the year can be decided later in the year based on resident preference.

Core Rotations (PGY2 Pediatrics)

  • General Pediatrics (4-5 weeks)
  • Neonatal Intensive Care Nursery-ICN I (4 weeks)
  • Pediatric Intensive Care Unit-PICU I (4 weeks)
  • Cardiac Intensive Care Unit-CICU I (4 weeks)
  • Hematology/Oncology I (5-6 weeks)
  • Hospital Administration & Medication Use Projects (7 weeks)
  • Pediatric Ambulatory Care Clinics (Cystic Fibrosis, Renal Transplant, Liver Transplant, Neurology) (5 weeks)

Longitudinal

  • Pharmacy Operations (52 weeks)
  • Education (Teaching & Precepting) (52 weeks)
  • Research (52 weeks)
  • Leadership Excellence (52 weeks)

Elective Rotations

  • Bone Marrow Transplant I (4-5 weeks)
  • Infectious Disease I, II (3-4 weeks)
  • Solid Organ Transplant/Transitional Care - Kidney, Liver, Heart (4 weeks)
  • Emergency Medicine (5-6 weeks)
  • Labor & Delivery - Obstetrics (2-4 weeks)
  • Critical Care - PICU II, CICU II, ICN II
  • Oncology/BMT - Heme/Onc II, BMT II
  • Transitions of Care (3-4 weeks) 

Operational Training

All residents receive comprehensive training in each of the operational areas during orientation, including formalized training in sterile compounding and aseptic technique. At the beginning of the residency year, residents are paired with an experienced preceptor who will oversee their operational staffing learning experience throughout the year and provide residents with summative feedback.

Staffing Areas

Operational staffing occurs longitudinally and takes place approximately every third weekend spanning throughout the residency year for a total of 16 weekends. Residents staff in the main pharmacy. Residents interested in additional chemotherapy satellite training may be trained and can staff in this area in addition to the main pharmacy. 

2015-2016 Research

Project Selection

The Residency Program Director collects project proposal submissions from clinical pharmacists for consideration as a resident research project on an annual basis in the Spring. Projects are reviewed for feasibility, appropriateness of timeline, potential value that may focus on clinical pharmacist services, quality improvement initiatives such as drug safety, optimal medication use, cost effective drug use, and efficient, safe and effective medication preparation, delivery and administration. The Residency Program Director will reach out to the residents in early summer to start discussion of project selection.

Research Training

PGY2 residents participate in the UCSF Research Certificate Program and will gain skills in adhering to a research timeline, creating an appropriate study design and methodology, completing data collection and analysis and summarizing research findings. Residents are enrolled in the Designing Clinical Research course that is part of the Summer Clinical Research Workshop. This interprofessional curriculum within the Department of Epidemiology & Biostatistics guides residents through modification of their research proposal and creation of a version suitable for submission to the UCSF Institutional Review Board. For projects requiring more advanced statistics, residents also receive support to work with the Clinical and Translational Science Institute (CTSI) in order to complete analysis. Residents will participate in a research certificate whereby they attend structured research sessions throughout the year in guiding the successful completion of the research project.

Poster & Platform Presentations

All projects are of a scope suitable for publication. Projects are presented as posters at the UCSF Department of Clinical Pharmacy Spring Research Poster Session. They are also presented as posters at the Vizient residency session that precedes the ASHP Midyear Clinical Meeting. The final presentation occurs in spring as a platform presentation at the Spring PPA National meeting. Final research project write up should be in a format suitable journal submission.

Previous PGY2 Pediatrics Resident Research Projects

Meagan Funasaki (2026) 

Does fosaprepitant administered prior to or with the first dose of busulfan lead to overshooting the predicted busulfan target AUC? 

Selena Li (2026) 

Use of sodium acetate fluid in extremely low birth weight premature infants 

Emily Leon (2025) 

Healthcare/Hospital Associated Trauma (HAT): Observed patient trauma and pharmacists perspectives on their own mental health 

Emily Lim (2025) 

Vancomycin dosing and pharmacokinetics in infants 6 months and younger post cardiac surgery 

Celia Boone (2024) 

Rapid vs. Standard Hydration Prior to Nephrotoxic Chemotherapy Agents in Pediatric Patients 

Veronika Omori (2024) 

Comparison of Two Dosing Strategies for Ganciclovir and Valganciclovir Prophylaxis and Treatment of Pediatric Cytomegalovirus 

Sophia Xue (2024) 

Evaluation of Vibrating Mesh Nebulizer vs. Jet Nebulizer in the Treatment of Acute Asthma Exacerbation with Albuterol in Admitted Pediatric Patients 

Jasmine Pare (2023) 

Evaluating Vancomycin Dosing in the Pediatric Patients in the Cardiac Intensive Care Unit 

Paige Ruffier (2023) 

Pediatric Dosing and Therapeutic Drug Monitoring of Isavuconazonium 

Mai Le-Madrigal (2022) 

Evaluation of a Surgical Prophylaxis Guideline Implementation in Pediatric Cardiac Patients 

Heather Wittkorn (2022) 

Diversity, Equity, and Inclusion - Assessing Antimicrobial Prescribing in the Emergency Department 

Jimin Lee (2021) 

Evaluation of Initial Doses for Opioid and Benzodiazepine Wean in Critically Ill Pediatric Patients 

Tran Nguyen (2021) 

Antithrombin III in Children with Congenital Heart Disease Surgeries with Chest Tubes 

Erin Wilson (2020) 

Evaluation of pharmacokinetic models to optimize early tacrolimus dosing in pediatric hematopoietic stem cell transplantation patients 

Ashley Wu (2020) 

Vancomycin Pharmacokinetics in Pediatric Patients 

Ferras Bashqoy (2019) 

Prophylactic Antibiotics in Endoscopic Retrograde Cholangiopancreatography in Pediatric Patients 

Nancy Koo (2019) 

Evaluation of a Delirium Risk Factor Screening Tool as a Predictor of Incidence of Delirium 

Allyson Thrall (2018) 

Retrospective comparison of calfactant versus poractant alfa in premature neonates 

Jessica Zook Frasher (2018) 

Evaluation of the impact of the Pediatric Critical Care Comfort Algorithm (CALM) sedation weaning protocol on medication use in the Pediatric Intensive Care Unit (PICU) 

Sylvia Okrzesik (2017) 

Utilization and Monitoring of Methadone in Pediatrics 

Patricia Kuang (2016) 

Impact of using population pharmacokinetic model-based dosing algorithm for initial dosing of busulfan in children less than 12 kilograms 

Katya Kurdyukova (2016) 

Utilization of QT prolonging medications in a tertiary children’s hospital 

Melissa Sandley (Rees) (2015) 

Retrospective investigation of busulfan pharmacokinetics and potential drug-interactions that impact drug exposure in pediatric patients undergoing hematopoietic stem cell transplantation 

Sylvia Stofella (2014) 

Development and Implementation of the Withdrawal Evaluation of Analgesia for Neonates (WEAN) Protocol 

Jane Mauro (Huh) (2014) 

Characterization of Tacrolimus levels in Pediatric Kidney Transplant Patients 

Jon Cokley (2013) 

Use of Vancomycin Continuous Mediastinal Irrigation in Pediatric Patients 

Shirley Chen (Lee) (2012) 

A Prolonged Gentamicin Dosing Interval Achieves Target Drug Concentrations in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia 

Dominique Mark (Bradford) (2011) 

Evaluation of New Valganciclovir Dosing Recommendations for Cytomegalovirus (CMV) in Pediatric Patients – A Monte Carlo Analysis 

Teaching

Teaching Instruction

Teaching is a focus of the residency at UCSF, and residents receive a Teaching Certificate upon program completion if they complete the required elements of the program. The certificate recognizes the significant contributions and skills that are attained during the residency year. Residents receive training in teaching methodology, precepting and small group conference facilitation through a variety of educational seminars that are planned during the year.

Teaching Experiences

Teaching opportunities may include the following:

  • Precepting of PGY1, APPE, and IPPE students on clinical rotations and project-based work
  • Large group teaching
    • Pediatric Elective Lecture
    • Continuing Pharmacy Education, UCSF Health
  • Small group teaching
  • Interprofessional education to nursing & physician groups
  • Conference Leader for Pediatric Elective & Therapeutics courses
  • Community outreach - Poison Prevention 

Overview

PGY2 Pediatric Pharmacy residents are integral members of the interprofessional emergency response care team. All PGY2 Pediatric Residents will become certified in Pediatric Advanced Life Support (PALS) and receive hands-on pediatric & adult code training. Residents respond to Code White (Pediatric), Code Blue (Adult), Seizure Rescue and participate in adult and pediatric stroke responses. During emergent response, residents ensure appropriate drug selection and administration, timeliness of medication retrieval and preparation, adjusting medication dosages and monitoring for response.

Simulation

PGY2 Pediatric Residents will participate in multidisciplinary mock codes throughout the year in both pediatric and adult clinical practice areas to practice their skills. 

Virtual Open House

Two annual open house events (SWEC early commitment, and Standard Enrollment) are offered in the fall for interested applicants. Attendees will have the opportunity to meet and ask questions regarding the program.

SWEC Early Commitment 

The Open House has already occurred. Dates for next year’s event will be announced in early fall.

Standard Enrollment 

Date 

Thursday, November 20, 2025, from 3 - 4 PM (PST) 

Zoom 

Meeting ID: 947 7732 2128 

Password: 189337 

RSVP 

Video 

Learn more about our program!